Ningbo MedicalSystem (China) Today

300439 Stock   11.61  0.11  0.96%   

Performance

10 of 100

 
Weak
 
Strong
OK

Odds Of Distress

Less than 1

 
High
 
Low
Very Small
Ningbo MedicalSystem is trading at 11.61 as of the 30th of November 2024, a 0.96 percent increase since the beginning of the trading day. The stock's open price was 11.5. Ningbo MedicalSystem has a very small chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for Ningbo MedicalSystem Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
Ningbo MedicalSystem is entity of China. It is traded as Stock on SHE exchange. The company has 383.95 M outstanding shares. More on Ningbo MedicalSystem Biotechnology

Moving together with Ningbo Stock

  0.88688256 Cambricon TechnologiesPairCorr
  0.95688047 Loongson Technology CorpPairCorr
  0.96688318 Shenzhen Fortune TrendPairCorr
  0.88600106 Chongqing Road BridgePairCorr
  0.82600769 Wuhan Xianglong PowerPairCorr
  0.86301269 Empyrean TechnologyPairCorr

Ningbo Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ningbo MedicalSystem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ningbo MedicalSystem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Thematic IdeaBiotech (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors)
Ningbo MedicalSystem's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ningbo MedicalSystem's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Ningbo MedicalSystem can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ningbo MedicalSystem's financial leverage. It provides some insight into what part of Ningbo MedicalSystem's total assets is financed by creditors.
Liquidity
Ningbo MedicalSystem cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Ningbo MedicalSystem Biotechnology has accumulated 50.05 M in total debt. Debt can assist Ningbo MedicalSystem until it has trouble settling it off, either with new capital or with free cash flow. So, Ningbo MedicalSystem's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ningbo MedicalSystem sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ningbo to invest in growth at high rates of return. When we think about Ningbo MedicalSystem's use of debt, we should always consider it together with cash and equity.

Dividends Paid

69.4 Million
Ningbo MedicalSystem Biotechnology (300439) is traded on Shenzhen Stock Exchange in China and employs 2,164 people. Ningbo MedicalSystem is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.46 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ningbo MedicalSystem's market, we take the total number of its shares issued and multiply it by Ningbo MedicalSystem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ningbo MedicalSystem operates under Biotechnology sector and is part of Health Care industry. The entity has 383.95 M outstanding shares. Ningbo MedicalSystem generates positive cash flow from operations, but has no cash available
Check Ningbo MedicalSystem Probability Of Bankruptcy
Ownership Allocation
Ningbo MedicalSystem maintains a total of 383.95 Million outstanding shares. Ningbo MedicalSystem Biotechnology holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ningbo Ownership Details

Ningbo MedicalSystem Risk Profiles

Although Ningbo MedicalSystem's alpha and beta are two of the key measurements used to evaluate Ningbo MedicalSystem's performance over the market, the standard measures of volatility play an important role as well.

Ningbo Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Ningbo MedicalSystem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Analyst Advice Now

   

Analyst Advice

Analyst recommendations and target price estimates broken down by several categories
All  Next Launch Module

Ningbo MedicalSystem Corporate Management

Elected by the shareholders, the Ningbo MedicalSystem's board of directors comprises two types of representatives: Ningbo MedicalSystem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ningbo. The board's role is to monitor Ningbo MedicalSystem's management team and ensure that shareholders' interests are well served. Ningbo MedicalSystem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ningbo MedicalSystem's outside directors are responsible for providing unbiased perspectives on the board's policies.
Liang FangDeputy ManagerProfile
Min ShenDeputy ManagerProfile
Huiping XiongFinancial GMProfile
Hui YeChief MangProfile

Other Information on Investing in Ningbo Stock

Ningbo MedicalSystem financial ratios help investors to determine whether Ningbo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ningbo with respect to the benefits of owning Ningbo MedicalSystem security.